Research Today • Hope For Tomorrow

MK-0431-845

Merck 845

MK-0431-845, Merck 845, is a double blind, placebo controlled clinical trial investigating the efficacy and safety of continuing Sitagliptin vs withdrawl of Sitagliptin and introduction of Insulin Glargine.

Contact us to learn more